Mellinghoff, I. K., Cloughesy, T., Alexander, B., Berry, D. A., Buxton, M., Cavenee, W., … Lee, E. (2024). LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. In Neuro-Oncology (Vol. 26, pp. viii1–viii1). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noae165.1302

Mellinghoff, Ingo K., Timothy Cloughesy, Brian Alexander, Donald A. Berry, Meredith Buxton, Webster Cavenee, Howard Colman, et al. “LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.” In Neuro-Oncology, 26:viii1–viii1. Oxford University Press (OUP), 2024. https://doi.org/10.1093/neuonc/noae165.1302.

Mellinghoff IK, Cloughesy T, Alexander B, Berry DA, Buxton M, Cavenee W, et al. LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. In: Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii1–viii1.

Mellinghoff, Ingo K., et al. “LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.” Neuro-Oncology, vol. 26, no. Supplement_8, Oxford University Press (OUP), 2024, pp. viii1–viii1. Crossref, doi:10.1093/neuonc/noae165.1302.

Mellinghoff IK, Cloughesy T, Alexander B, Berry DA, Buxton M, Cavenee W, Colman H, de Groot J, Ellingson BM, Gordon GB, Lassman AB, Lim M, Khasraw M, Perry J, Sulman EP, Weller M, Wen P, Yung WKA, Berry N, Graves T, Detry M, Hyddmark EMV, Johnsson A, Kling H, McGlothlin A, Powell A, Untch S, Aquilanti E, Blondin N, Boulmay B, de la Fuente M, Drappatz J, Jordan J, Kaley TJ, Lobbous M, Mikkelsen T, Newton H, Owen S, Peters K, Schiff D, Sherman W, Weathers S-P, Youssef M, Friend J, Lee E. LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii1–viii1.